Odyssey Health, Inc. (ODYY)
| Market Cap | 738.47K -92.9% |
| Revenue (ttm) | n/a |
| Net Income | -3.57M |
| EPS | -0.04 |
| Shares Out | 110.22M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 26,030 |
| Open | 0.006996 |
| Previous Close | n/a |
| Day's Range | 0.0067 - 0.006996 |
| 52-Week Range | 0.0041 - 0.1250 |
| Beta | -1.45 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Oct 29, 2026 |
About Odyssey Health
Odyssey Health, Inc., a medical company, focuses on the development and acquisition of medical products and health related technologies. The company develops CardioMap, a heart monitoring and screening device; and Save A Life choking rescue devices. Its product candidates include ONP-002 for the treatment of mild brain trauma or concussion. The company was formerly known as Odyssey Group International, Inc. Odyssey Health, Inc. was incorporated in 2014 and is based in Las Vegas, Nevada. [Read more]
Financial Performance
Financial StatementsNews
Odyssey Health, Inc. Secures Exclusive Global Distribution Rights for BreastCheck™ to Drive Recurring Revenue Growth
Agreement Positions Company for Near-Term Revenue and Commercial Launch LAS VEGAS, April 22, 2026 /PRNewswire/ -- Odyssey Health, Inc. (OTCQB: ODYY), a medical device company focused on life-saving te...
Odyssey Health, Inc. Secures Multi-Million-Dollar, Nine-Year Service Contract and Financing Facility for Up to $25 Million
Service agreement and financing facility supports strategic growth and commercialization initiatives Service agreement and financing facility supports strategic growth and commercialization initiative...
Odyssey Health, Inc., Enters the $26 Billion Breast Cancer Marketplace
Odyssey Medical Devices, Inc., a subsidiary of Odyssey Health Inc., to acquire exclusive global marketing and distribution rights for the BreastCheck® Odyssey Medical Devices, Inc., a subsidiary of Od...
Odyssey Health, Inc. to Advance Development of its Save A Life Choking Rescue Device
LAS VEGAS, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTCQB: ODYY) (the “Company” or “Odyssey”), a technology and asset acquisition company focused on developing unique, life-saving medic...
Odyssey Health, Inc. Strengthens Balance Sheet with $8.7 Million in Net Equity
LAS VEGAS, NV / ACCESSWIRE / March 27, 2024 / Odyssey Health, Inc. (OTCQB:ODYY), formerly Odyssey Group International, Inc., (the "Company") a company focused on developing unique, life-enhancing medi...
Odyssey Health Closes Asset Sale of its Neurological Drug Technology Pipeline Including Concussion Drug Candidate with Oragenics, Inc.
LAS VEGAS, NV / ACCESSWIRE / January 2, 2024 / Odyssey Health, Inc. (OTCQB:ODYY) ("Odyssey" or the "Company") today announces the closing of the definitive Asset Purchase Agreement, that was entered i...
Odyssey Health, Inc. Gains Shareholder Approval for Asset Sale with Oragenics, Inc.
LAS VEGAS, NV / ACCESSWIRE / December 12, 2023 / Odyssey Health, Inc. (OTCOB:ODYY), a company focused on developing unique, life-enhancing medical products including a drug treatment intended to treat...
Odyssey Health, Inc, Selects Syneos Health to Support Investigational New Drug Application for Treatment of Concussion
LAS VEGAS, NV / ACCESSWIRE / November 16, 2023 / Odyssey Health, Inc. (OTCQB:ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products, ha...
Odyssey Health, Inc. to Provide Company Update and Webcast for Shareholders
LAS VEGAS, NV / ACCESSWIRE / November 15, 2023 / Odyssey Health, Inc. (OTCQB:ODYY), formerly Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products,...
Odyssey Health, Inc. Provides Update on Asset Purchase Agreement with Oragenics, Inc.
LAS VEGAS, NV / ACCESSWIRE / October 18, 2023 / Odyssey Health, Inc. (OTCQB:ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products is p...
Odyssey Health Inc. Begins Trading on the OTCQB
LAS VEGAS, NV / ACCESSWIRE / October 4, 2023 / Odyssey Health, Inc. (formerly known as Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"), is a medical device and pharmaceutic...
Odyssey Health, Inc. Presents Concussion Treatment Data at the Military Health System Research Symposium - MHSRS
LAS VEGAS, NV / ACCESSWIRE / August 23, 2023 / Odyssey Health, Inc. (OTC:ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products, recent...
Odyssey Health, Inc. Presents Data at the Special Operations Medical Association - Scientific Assembly
LAS VEGAS, NV / ACCESSWIRE / June 8, 2023 / Odyssey Health, Inc. (OTCQB:ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products, recentl...
Brett Favre Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
ORLANDO, FL / ACCESSWIRE / July 14, 2022 / RedChip Companies will air a new interview with Odyssey Health, Inc. (OTC Pink:ODYY), f/k/a Odyssey Group International, Inc., on The RedChip Money Report® o...
RedChip Interviews Odyssey Health, Inc.'s CEO Michael Redmond
Las Vegas, NV, June 08, 2022 (GLOBE NEWSWIRE) -- RedChip Companies will air a new C-Level interview with Odyssey Health, Inc. (OTC Pink: ODYY), f/k/a Odyssey Group International, Inc. on The RedChip M...
Odyssey Group International Files Patent On Novel Breath-Propelled Nasal Delivery Device
IRVINE, CA, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC:ODYY) (the "Company" or "Odyssey"), a medical technology company focused on developing unique, life-saving medica...
Odyssey Group International Begins Enrolling Subjects for Phase 1 Clinical Trial to Treat Concussion
IRVINE, CA, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC: ODYY) (the "Company" or "Odyssey"), a medical company focused on developing unique, life-saving medical products...
Odyssey Group International Approved to Start Human Trial to Treat Concussion
IRVINE, CA, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC: ODYY) (the "Company" or "Odyssey"), a company focused on developing unique, life-saving medical products, today ...
Odyssey Group International Completes IND-enabling Studies, Submits Investigator's Brochure for Phase 1 Clinical Trial
IRVINE, CA, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC: ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique, life...
Odyssey Group International, Inc. Provides Notice of Annual Meeting of Stockholders
IRVINE, CA, July 26, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB: ODYY) ("ODYY" or "the Company"), Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"), a...
Odyssey Group International Reports Achieving Drug Safety Standards for Clinical Trials of its Drug for Treating Concussion
IRVINE, CA, June 29, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB: ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique, li...
Odyssey Group International to Present at LD Micro Virtual Investor Conference
IRVINE, CA, June 08, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB: ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique, l...
Odyssey Group International Announces Successful Completion of Their Novel Nano-Particle Drug Formulation for Treating Concussion
Irvine, CA, June 02, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB: ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique, li...
Odyssey Group International Announces Successful Toxicology Studies for its Concussion Drug
Enters Agreement with Contract Research Organization for Phase 1 Trial Enters Agreement with Contract Research Organization for Phase 1 Trial
Odyssey Group International, Inc. Schedules Annual Meeting of Stockholders
IRVINE, CA, May 24, 2021 (GLOBE NEWSWIRE) -- – Odyssey Group International, Inc. (OTCQB: ODYY) ("ODYY" or "the Company"), Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"), a...